Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13.1M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
12M
-
Shares change
-
-140K
-
Total reported value, excl. options
-
$516M
-
Value change
-
-$4.65M
-
Number of buys
-
62
-
Number of sells
-
-71
-
Price
-
$42.80
Significant Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q2 2021
160 filings reported holding EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock as of Q2 2021.
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
of 13.1M outstanding shares and own 92.12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.08M shares), JANUS HENDERSON GROUP PLC (1.53M shares), VANGUARD GROUP INC (753K shares), STATE STREET CORP (738K shares), BRANDES INVESTMENT PARTNERS, LP (717K shares), JPMORGAN CHASE & CO (345K shares), Invesco Ltd. (317K shares), DIMENSIONAL FUND ADVISORS LP (301K shares), Smith, Graham & Co., Investment Advisors, LP (278K shares), and ACADIAN ASSET MANAGEMENT LLC (262K shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.